Kayne Anderson Rudnick Investment Management LLC Ptc Therapeutics, Inc. Transaction History

Kayne Anderson Rudnick Investment Management LLC

$43.7 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$25.6 - $45.23 $1,126 - $1,990	-44 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $1,466 - $1,962	44 New	44 $2,000
Q1 2021 May 17, 2021	SELL	$46.8 - $68.92 $608 - $895	-13 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$47.96 - $67.64 $623 - $879	13 New	13 $1,000

Others Institutions Holding PTCT

# of Institutions

221

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

Vanguard Group Inc Valley Forge, PA

9.13M
Shares

$425 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

7.89M
Shares

$367 Million
0.05% of portfolio
Black Rock Inc. New York, NY

7.77M
Shares

$362 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

7.39M
Shares

$344 Million
4.37% of portfolio
Armistice Capital, LLC New York, NY

7.23M
Shares

$337 Million
4.46% of portfolio

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.33B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Account